Cargando…

Lipoprotein(a) is a Promising Residual Risk Factor for Long-Term Clinical Prognosis in Peripheral Arterial Disease

Objectives: We investigated the relationship between plasma lipoprotein(a) [Lp(a)] level and long-term prognosis, cardiovascular events, or pure leg events (LE) in patients with peripheral arterial disease (PAD). Materials and Methods: We prospectively enrolled 1104 PAD patients. The endpoints were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakata, Kimimasa, Kumakura, Hisao, Funada, Ryuichi, Matsuo, Yae, Nakashima, Kuniki, Iwasaki, Toshiya, Ichikawa, Shuichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese College of Angiology / The Japanese Society for Vascular Surgery / Japanese Society of Phlebology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558143/ https://www.ncbi.nlm.nih.gov/pubmed/36310737 http://dx.doi.org/10.3400/avd.oa.22-00046

Ejemplares similares

Influence of Microalbuminuria on Long-Term Survival and Cardiovascular or Limb Events in Peripheral Arterial Disease
por: Nakashima, Kuniki, et al.
Publicado: (2021)

The Geriatric Nutritional Risk Index Predicts Long-Term Survival and Cardiovascular or Limb Events in Peripheral Arterial Disease
por: Matsuo, Yae, et al.
Publicado: (2020)

Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure
por: Matsuo, Yae, et al.
Publicado: (2016)

Lipoprotein(a): A Promising Marker for Residual Cardiovascular Risk Assessment
por: Cai, Anping, et al.
Publicado: (2013)

Infrainguinal Lesion of Peripheral Artery Disease and Levels of ω-3 Polyunsaturated Fatty Acids in Peripheral Artery Disease
por: Iwasaki, Tomoaki, et al.
Publicado: (2018)

Synergistic effect of lipoprotein (a) and C-reactive protein on prognosis of familial hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Residual Risk Still Remains in Low-Density Lipoprotein
por: Hirano, Tsutomu
Publicado: (2022)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

High-density lipoprotein cholesterol as a therapeutic target for residual risk in patients with acute coronary syndrome
por: Ozaki, Yuichi, et al.
Publicado: (2018)

Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease
por: Levin, Michael G., et al.
Publicado: (2021)

Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
por: Lawler, Patrick R., et al.
Publicado: (2017)

Association between lipoprotein(a) and peripheral arterial disease in coronary artery bypass grafting patients
por: Yi, Cheng, et al.
Publicado: (2023)

Correlation between plasma lipoprotein-associated phospholipase A(2) and peripheral arterial disease
por: LI, SHUAI-BING, et al.
Publicado: (2013)

Beyond LDL: Understanding Triglyceride-Rich Lipoproteins to Tackle Residual Risk
por: Gugliucci, Alejandro
Publicado: (2023)

Enhanced synthesis of 5-hydroxy-l-tryptophan through tetrahydropterin regeneration
por: Hara, Ryotaro, et al.
Publicado: (2013)

Performance change with the number of training data: A case study on the binary classification of COVID-19 chest X-ray by using convolutional neural networks
por: Imagawa, Kuniki, et al.
Publicado: (2022)

Personalized Medicine beyond Low-Density Lipoprotein Cholesterol to Combat Residual Risk for Coronary Artery Disease
por: Tada, Hayato
Publicado: (2021)

Synergistic effect of the commonest residual risk factors, remnant cholesterol, lipoprotein(a), and inflammation, on prognosis of statin-treated patients with chronic coronary syndrome
por: Liu, Hui-Hui, et al.
Publicado: (2022)

Precision Nutrition and Cardiovascular Disease Risk Reduction: the Promise of High-Density Lipoproteins
por: Hong, Brian V., et al.
Publicado: (2023)

Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease
por: Golledge, Jonathan, et al.
Publicado: (2020)

Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts
por: Laschkolnig, Anja, et al.
Publicado: (2014)

Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma
por: Uccello, Mario, et al.
Publicado: (2011)

Is Lipoprotein(a) the Most Important Predictor of Residual Atherosclerotic Cardiovascular Disease Risk?
por: Wong, Nathan D.
Publicado: (2022)

The association of DNA-dependent protein kinase activity of peripheral blood lymphocytes with prognosis of cancer
por: Someya, M, et al.
Publicado: (2011)

SUCCESSFUL TRANSPLANTATION OF MOTONEURONS INTO THE PERIPHERAL NERVE DEPENDS ON THE NUMBER OF TRANSPLANTED CELLS
por: KATO, SHUICHI, et al.
Publicado: (2015)

Monocyte/High-Density Lipoprotein Ratio Predicts the Prognosis of Large Artery Atherosclerosis Ischemic Stroke
por: Li, Youyu, et al.
Publicado: (2021)

Association of Oxidized Low-Density Lipoprotein in Nonalcoholic Fatty Liver Disease with High-Risk Plaque on Coronary Computed Tomography Angiography: A Matched Case–Control Study
por: Nishihara, Takahiro, et al.
Publicado: (2022)

Serum high-density lipoprotein level and prognosis of ovarian cancer
por: Hongyan, Jiang, et al.
Publicado: (2023)

The Association of Triglyceride to High-Density Lipoprotein Cholesterol Ratio with High-Risk Coronary Plaque Characteristics Determined by CT Angiography and Its Risk of Coronary Heart Disease
por: Koide, Yuji, et al.
Publicado: (2022)

Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins
por: Lawler, Patrick R., et al.
Publicado: (2017)

Identification and Application of Two Promising Peptide Ligands for the Immunodetection of Imidacloprid Residue
por: You, Tianyang, et al.
Publicado: (2022)

Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development
por: Huang, Fangjiao, et al.
Publicado: (2022)

Lipoprotein (a): a promising prognostic biomarker in patients with hepatocellular carcinoma after curative resection
por: Gao, Xing-hui, et al.
Publicado: (2018)

Alzheimer's disease mechanisms in peripheral cells: Promises and challenges
por: Trushina, Eugenia
Publicado: (2019)

Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study
por: Tani, Shigemasa, et al.
Publicado: (2017)

Lipoprotein(a) as a Higher Residual Risk for Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus than without
por: Yu, Bingyan, et al.
Publicado: (2023)

Huge racemose hemangioma of the bronchial artery with arterial supply via the right coronary artery and left internal thoracic artery
por: Horie, Rikako, et al.
Publicado: (2022)

Circulating nerve growth factor receptor positive cells are associated with severity and prognosis of pulmonary arterial hypertension
por: Goten, Chiaki, et al.
Publicado: (2021)

Reducing residual thrombotic risk in patients with peripheral artery disease: impact of the COMPASS trial
por: Hernández, José Luis, et al.
Publicado: (2020)

Oxidized low-density lipoprotein and ankle-brachial pressure index in patients with clinically evident peripheral arterial disease
por: Rosoky, Ruben Miguel Ayzin, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_k495tgrjt0cbukedohej9h1boi